Overview
I have a strong belief that all children diagnosed with cancer should have the same chance of cure regardless of where they live. Since 2014, i have spent six or more months per year in Mwanza, Tanzania, at the Bugando Medical Centre as part of the Duke Global Cancer Program. In addition to developing capacity for pediatric cancer care, my research focuses on creating interventions to improve outcomes and reducing treatment abandonment in low resource settings.
As a trained pediatric neuro-oncologist, I am also involved in neuro-oncology capacity development in Sub-Saharan Africa, and am collaborating with a multidisciplinary team in Tanzania to establish diagnostic and treatment opportunities for patients.
As a trained pediatric neuro-oncologist, I am also involved in neuro-oncology capacity development in Sub-Saharan Africa, and am collaborating with a multidisciplinary team in Tanzania to establish diagnostic and treatment opportunities for patients.
Current Appointments & Affiliations
Associate Professor of Pediatrics
·
2023 - Present
Pediatrics, Hematology-Oncology,
Pediatrics
Associate Research Professor of Global Health
·
2023 - Present
Duke Global Health Institute,
University Institutes and Centers
Member of the Duke Cancer Institute
·
2020 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Implementation Science Methodology for the Successful Introduction of High-Dose Methotrexate for the Treatment of Pediatric Mature B-Cell Non-Hodgkin Lymphoma in a Resource-Limited Setting.
Journal Article Pediatr Blood Cancer · January 5, 2026 BACKGROUND: Despite the excellent outcomes achieved for pediatric mature B-cell non-Hodgkin lymphoma (MB-NHL) in high-income countries, outcomes remain very poor in low- and middle-income countries. High-dose methotrexate (HD-MTX), which is highly efficaci ... Full text Link to item CiteChemotherapy-Induced Toxicities in Pediatric Cancer Patients: A Cross-Sectional Survey Using a Child- and Caregiver-Reported Outcome Tool in Tanzania
Journal Article Drug Healthcare and Patient Safety · January 1, 2026 Background: Chemotherapy remains the cornerstone of pediatric cancer treatment, yet its cytotoxic nature often results in chemotherapy-induced toxicities, adverse effects arising from damage to healthy, rapidly dividing cells. Data describing these toxicit ... Full text CiteProspective psychometric validation of the Swahili translated and adapted Pediatric Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE)
Journal Article Measurement and Evaluations in Cancer Care · December 2025 Full text CiteRecent Grants
Improving access to cancer care for children in Tanzania: Designing a health-systems intervention
ResearchAdvisor · Awarded by Fogarty International Center · 2022 - 2027Multimedia caregiver education program to improve outcomes for children with cancer in low-resource settings
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2026Improving Chemotherapy Safe Handling at Bugando Medical Center
ResearchSignificant Contributor · Awarded by Perrysburg Rotary Service Foundation · 2022 - 2024View All Grants
Education, Training & Certifications
Georgetown University, School of Medicine ·
2007
M.D.
West Virginia University ·
2002
M.P.H.